Global Prostate Cancer Therapeutic Sales Market Report 2016

Global Prostate Cancer Therapeutic Sales Market Report 2016

1 Prostate Cancer Therapeutic Overview

1.1 Product Overview and Scope of Prostate Cancer Therapeutic

1.2 Classification of Prostate Cancer Therapeutic

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Prostate Cancer Therapeutic

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Prostate Cancer Therapeutic Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Prostate Cancer Therapeutic (2011-2021)

1.5.1 Global Prostate Cancer Therapeutic Sales and Growth Rate (2011-2021)

1.5.2 Global Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

2 Global Prostate Cancer Therapeutic Competition by Manufacturers, Type and Application

2.1 Global Prostate Cancer Therapeutic Market Competition by Manufacturers

2.1.1 Global Prostate Cancer Therapeutic Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Prostate Cancer Therapeutic Revenue and Share by Manufacturers (2011-2016)

2.2 Global Prostate Cancer Therapeutic (Volume and Value) by Type

2.2.1 Global Prostate Cancer Therapeutic Sales and Market Share by Type (2011-2016)

2.2.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)

2.3 Global Prostate Cancer Therapeutic (Volume and Value) by Regions

2.3.1 Global Prostate Cancer Therapeutic Sales and Market Share by Regions (2011-2016)

2.3.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Regions (2011-2016)

2.4 Global Prostate Cancer Therapeutic (Volume) by Application

3 USA Prostate Cancer Therapeutic (Volume, Value and Sales Price)

3.1 USA Prostate Cancer Therapeutic Sales and Value (2011-2016)

3.1.1 USA Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

3.1.2 USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

3.1.3 USA Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

3.2 USA Prostate Cancer Therapeutic Sales and Market Share by Manufacturers

3.3 USA Prostate Cancer Therapeutic Sales and Market Share by Type

3.4 USA Prostate Cancer Therapeutic Sales and Market Share by Application

4 China Prostate Cancer Therapeutic (Volume, Value and Sales Price)

4.1 China Prostate Cancer Therapeutic Sales and Value (2011-2016)

4.1.1 China Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

4.1.2 China Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

4.1.3 China Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

4.2 China Prostate Cancer Therapeutic Sales and Market Share by Manufacturers

4.3 China Prostate Cancer Therapeutic Sales and Market Share by Type

4.4 China Prostate Cancer Therapeutic Sales and Market Share by Application

5 Europe Prostate Cancer Therapeutic (Volume, Value and Sales Price)

5.1 Europe Prostate Cancer Therapeutic Sales and Value (2011-2016)

5.1.1 Europe Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

5.1.2 Europe Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

5.1.3 Europe Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

5.2 Europe Prostate Cancer Therapeutic Sales and Market Share by Manufacturers

5.3 Europe Prostate Cancer Therapeutic Sales and Market Share by Type

5.4 Europe Prostate Cancer Therapeutic Sales and Market Share by Application

6 Japan Prostate Cancer Therapeutic (Volume, Value and Sales Price)

6.1 Japan Prostate Cancer Therapeutic Sales and Value (2011-2016)

6.1.1 Japan Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

6.1.2 Japan Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

6.1.3 Japan Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

6.2 Japan Prostate Cancer Therapeutic Sales and Market Share by Manufacturers

6.3 Japan Prostate Cancer Therapeutic Sales and Market Share by Type

6.4 Japan Prostate Cancer Therapeutic Sales and Market Share by Application

7 India Prostate Cancer Therapeutic (Volume, Value and Sales Price)

7.1 India Prostate Cancer Therapeutic Sales and Value (2011-2016)

7.1.1 India Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

7.1.2 India Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

7.1.3 India Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

7.2 India Prostate Cancer Therapeutic Sales and Market Share by Manufacturers

7.3 India Prostate Cancer Therapeutic Sales and Market Share by Type

7.4 India Prostate Cancer Therapeutic Sales and Market Share by Application

8 Southeast Asia Prostate Cancer Therapeutic (Volume, Value and Sales Price)

8.1 Southeast Asia Prostate Cancer Therapeutic Sales and Value (2011-2016)

8.1.1 Southeast Asia Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

8.2 Southeast Asia Prostate Cancer Therapeutic Sales and Market Share by Manufacturers

8.3 Southeast Asia Prostate Cancer Therapeutic Sales and Market Share by Type

8.4 Southeast Asia Prostate Cancer Therapeutic Sales and Market Share by Application

9 Global Prostate Cancer Therapeutic Manufacturers Analysis

9.1 Pfizer Inc. (USA)

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Prostate Cancer Therapeutic Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Abbott Laboratories (USA)

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 125 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Abbott Laboratories (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Genentech Inc. (USA)

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 147 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Genentech Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 GlaxoSmithKline Plc (UK)

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Immunomedics, Inc. (USA)

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Indevus Pharmaceuticals Inc. (USA)

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Novartis AG (Switzerland)

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Novartis AG (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 OSI Pharmaceuticals, Inc. (USA)

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Paladin Labs Inc. (Canada)

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 ALZA Corporation (USA)

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 ALZA Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Amgen Inc. (USA)

9.12 AstraZeneca PLC (UK)

9.13 Medimmune, LLC (USA)

9.14 Bristol-Myers Squibb Company (USA)

9.15 Cell Genesys Inc. (USA)

9.16 Dendreon Corporation (USA)

9.17 EUSA Pharma, (USA) Inc. (USA)

9.18 F. Hoffmann-La Roche Ltd. (Switzerland)

9.19 Progenics Pharmaceuticals, Inc. (USA)

9.20 Sanofi-Aventis SA (France)

9.21 Spectrum Pharmaceuticals, Inc. (USA)

9.22 Takeda Pharmaceutical Company Limited (Japan)

10 Prostate Cancer Therapeutic Maufacturing Cost Analysis

10.1 Prostate Cancer Therapeutic Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Prostate Cancer Therapeutic

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Prostate Cancer Therapeutic Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Prostate Cancer Therapeutic Market Forecast (2016-2021)

14.1 Global Prostate Cancer Therapeutic Sales, Revenue Forecast (2016-2021)

14.2 Global Prostate Cancer Therapeutic Sales Forecast by Regions (2016-2021)

14.3 Global Prostate Cancer Therapeutic Sales Forecast by Type (2016-2021)

14.4 Global Prostate Cancer Therapeutic Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Prostate Cancer Therapeutic

Table Classification of Prostate Cancer Therapeutic

Figure Global Sales Market Share of Prostate Cancer Therapeutic by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Prostate Cancer Therapeutic

Figure Global Sales Market Share of Prostate Cancer Therapeutic by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

Figure China Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

Figure Europe Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

Figure Japan Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

Figure India Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

Figure Global Prostate Cancer Therapeutic Sales and Growth Rate (2011-2021)

Figure Global Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2021)

Table Global Prostate Cancer Therapeutic Sales of Key Manufacturers (2011-2016)

Table Global Prostate Cancer Therapeutic Sales Share by Manufacturers (2011-2016)

Figure 2015 Prostate Cancer Therapeutic Sales Share by Manufacturers

Figure 2016 Prostate Cancer Therapeutic Sales Share by Manufacturers

Table Global Prostate Cancer Therapeutic Revenue by Manufacturers (2011-2016)

Table Global Prostate Cancer Therapeutic Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers

Table 2016 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers

Table Global Prostate Cancer Therapeutic Sales and Market Share by Type (2011-2016)

Table Global Prostate Cancer Therapeutic Sales Share by Type (2011-2016)

Figure Sales Market Share of Prostate Cancer Therapeutic by Type (2011-2016)

Figure Global Prostate Cancer Therapeutic Sales Growth Rate by Type (2011-2016)

Table Global Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)

Table Global Prostate Cancer Therapeutic Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Prostate Cancer Therapeutic by Type (2011-2016)

Figure Global Prostate Cancer Therapeutic Revenue Growth Rate by Type (2011-2016)

Table Global Prostate Cancer Therapeutic Sales and Market Share by Regions (2011-2016)

Table Global Prostate Cancer Therapeutic Sales Share by Regions (2011-2016)

Figure Sales Market Share of Prostate Cancer Therapeutic by Regions (2011-2016)

Figure Global Prostate Cancer Therapeutic Sales Growth Rate by Regions (2011-2016)

Table Global Prostate Cancer Therapeutic Revenue and Market Share by Regions (2011-2016)

Table Global Prostate Cancer Therapeutic Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Prostate Cancer Therapeutic by Regions (2011-2016)

Figure Global Prostate Cancer Therapeutic Revenue Growth Rate by Regions (2011-2016)

Table Global Prostate Cancer Therapeutic Sales and Market Share by Application (2011-2016)

Table Global Prostate Cancer Therapeutic Sales Share by Application (2011-2016)

Figure Sales Market Share of Prostate Cancer Therapeutic by Application (2011-2016)

Figure Global Prostate Cancer Therapeutic Sales Growth Rate by Application (2011-2016)

Figure USA Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

Figure USA Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

Figure USA Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

Table USA Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)

Table USA Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)

Table USA Prostate Cancer Therapeutic Sales by Type (2011-2016)

Table USA Prostate Cancer Therapeutic Market Share by Type (2011-2016)

Table USA Prostate Cancer Therapeutic Sales by Application (2011-2016)

Table USA Prostate Cancer Therapeutic Market Share by Application (2011-2016)

Figure China Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

Figure China Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

Figure China Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

Table China Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)

Table China Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)

Table China Prostate Cancer Therapeutic Sales by Type (2011-2016)

Table China Prostate Cancer Therapeutic Market Share by Type (2011-2016)

Table China Prostate Cancer Therapeutic Sales by Application (2011-2016)

Table China Prostate Cancer Therapeutic Market Share by Application (2011-2016)

Figure Europe Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

Figure Europe Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

Figure Europe Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

Table Europe Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)

Table Europe Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)

Table Europe Prostate Cancer Therapeutic Sales by Type (2011-2016)

Table Europe Prostate Cancer Therapeutic Market Share by Type (2011-2016)

Table Europe Prostate Cancer Therapeutic Sales by Application (2011-2016)

Table Europe Prostate Cancer Therapeutic Market Share by Application (2011-2016)

Figure Japan Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

Figure Japan Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

Figure Japan Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

Table Japan Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)

Table Japan Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)

Table Japan Prostate Cancer Therapeutic Sales by Type (2011-2016)

Table Japan Prostate Cancer Therapeutic Market Share by Type (2011-2016)

Table Japan Prostate Cancer Therapeutic Sales by Application (2011-2016)

Table Japan Prostate Cancer Therapeutic Market Share by Application (2011-2016)

Figure India Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

Figure India Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

Figure India Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

Table India Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)

Table India Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)

Table India Prostate Cancer Therapeutic Sales by Type (2011-2016)

Table India Prostate Cancer Therapeutic Market Share by Type (2011-2016)

Table India Prostate Cancer Therapeutic Sales by Application (2011-2016)

Table India Prostate Cancer Therapeutic Market Share by Application (2011-2016)

Figure Southeast Asia Prostate Cancer Therapeutic Sales and Growth Rate (2011-2016)

Figure Southeast Asia Prostate Cancer Therapeutic Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Prostate Cancer Therapeutic Sales Price Trend (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Sales by Manufacturers (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Market Share by Manufacturers (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Sales by Type (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Market Share by Type (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Sales by Application (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Market Share by Application (2011-2016)

Table Pfizer Inc. (USA) Basic Information List

Table Pfizer Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information List

Table Abbott Laboratories (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Genentech Inc. (USA) Basic Information List

Table Genentech Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information List

Table GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Immunomedics, Inc. (USA) Basic Information List

Table Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Indevus Pharmaceuticals Inc. (USA) Basic Information List

Table Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Novartis AG (Switzerland) Basic Information List

Table Novartis AG (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG (Switzerland) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table OSI Pharmaceuticals, Inc. (USA) Basic Information List

Table OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Paladin Labs Inc. (Canada) Basic Information List

Table Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table ALZA Corporation (USA) Basic Information List

Table ALZA Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ALZA Corporation (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Amgen Inc. (USA) Basic Information List

Table Amgen Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table AstraZeneca PLC (UK) Basic Information List

Table AstraZeneca PLC (UK) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AstraZeneca PLC (UK) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Medimmune, LLC (USA) Basic Information List

Table Medimmune, LLC (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Medimmune, LLC (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Bristol-Myers Squibb Company (USA) Basic Information List

Table Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb Company (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Cell Genesys Inc. (USA) Basic Information List

Table Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cell Genesys Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Dendreon Corporation (USA) Basic Information List

Table Dendreon Corporation (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Dendreon Corporation (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table EUSA Pharma, (USA) Inc. (USA) Basic Information List

Table EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure EUSA Pharma, (USA) Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure F. Hoffmann-La Roche Ltd. (Switzerland) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List

Table Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Progenics Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Sanofi-Aventis SA (France) Basic Information List

Table Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi-Aventis SA (France) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List

Table Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Spectrum Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List

Table Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Takeda Pharmaceutical Company Limited (Japan) Prostate Cancer Therapeutic Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Prostate Cancer Therapeutic

Figure Manufacturing Process Analysis of Prostate Cancer Therapeutic

Figure Prostate Cancer Therapeutic Industrial Chain Analysis

Table Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015

Table Major Buyers of Prostate Cancer Therapeutic

Table Distributors/Traders List

Figure Global Prostate Cancer Therapeutic Sales and Growth Rate Forecast (2016-2021)

Figure Global Prostate Cancer Therapeutic Revenue and Growth Rate Forecast (2016-2021)

Table Global Prostate Cancer Therapeutic Sales Forecast by Regions (2016-2021)

Table Global Prostate Cancer Therapeutic Sales Forecast by Type (2016-2021)

Table Global Prostate Cancer Therapeutic Sales Forecast by Application (2016-2021)